feinstein-institutes-for-medical-research

Migration, Crosslink

📖

feinstein-institutes-for-medical-research

active

wiki page Created: 2026-04-02T07:20:10 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-institutions-feinstein-institutes-f

📖 Wiki Page

institution1701 wordssynced 2026-04-02

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Feinstein Institutes for Medical Research</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Manhasset, NY, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Medical Research Institute</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.feinsteininstitutes.org/" target="_blank">https://www.feinsteininstitutes.org/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [Neuroinflammation](/mechanisms/neuroinflammation), [Autoimmunity](/mechanisms/autoimmunity)</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1949</td>
</tr>
</table>

Feinstein Institutes for Medical Research

Introduction

...

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Feinstein Institutes for Medical Research</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Manhasset, NY, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Medical Research Institute</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.feinsteininstitutes.org/" target="_blank">https://www.feinsteininstitutes.org/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [Neuroinflammation](/mechanisms/neuroinflammation), [Autoimmunity](/mechanisms/autoimmunity)</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1949</td>
</tr>
</table>

Feinstein Institutes for Medical Research

Introduction

Mermaid diagram (expand to render)

The Feinstein Institutes for Medical Research is the research arm of Northwell Health (formerly North Shore-LIJ Health System), located in Manhasset, New York. Founded in 1949 as the Long Island Jewish-Hillside Medical Center research division, the institute has grown into one of the nation's leading medical research organizations, comprising more than 50 research labs across multiple disease areas. The institutes are named after philanthropist Feinstein, who made significant contributions to medical research.

The Feinstein Institutes represent a critical component in neurodegenerative disease research, with particular strength in neuroimmunology—the study of how the immune system interacts with and affects the nervous system. This expertise has made the institutes a leader in understanding the role of neuroinflammation in Alzheimer's disease, Parkinson's disease, ALS, and multiple sclerosis.

Research Structure

Center for Neurodegenerative Diseases

The Feinstein Institutes house a dedicated Center for Neurodegenerative Diseases focused on understanding the cellular and molecular mechanisms of neurodegeneration and developing novel therapeutic approaches. The center brings together researchers from multiple disciplines to tackle the complex challenge of neurodegenerative disease.

Key research areas include:

Neuroinflammation: Studies on the role of the immune system in neurodegenerative diseases [@anderson2019]
Biomarker Discovery: Identification of diagnostic and prognostic biomarkers [@cho2019]
Therapeutic Development: Small molecule and biologic therapeutics for AD, PD, and related disorders
Stem Cell Research: Patient-derived stem cells for disease modeling [@li2021]
TREM2 Biology: Understanding microglial receptors in Alzheimer's disease pathogenesis

Immunology and Inflammation Research

The Feinstein Institutes are internationally recognized for immunology research, with particular expertise in:

Cytokine Biology and Signaling: Understanding inflammatory mediators in disease
T-cell and B-cell Function: Adaptive immune responses in neurodegeneration
Innate Immune Responses: Macrophages, microglia, and natural killer cells
Autoimmune Mechanisms in Neurological Disease: How autoimmunity contributes to neurodegeneration [@diamond2011]

Neuroimmunology Program

The neuroimmunology program represents a key focus area, investigating the intersection of the immune and nervous systems:

Cholinergic Anti-Inflammatory Pathway

Research led by Dr. Kevin J. Tracey has pioneered understanding of the vagus nerve-mediated anti-inflammatory pathway. This "inflammatory reflex" represents a neural circuit that controls immune responses through acetylcholine signaling [@tracey2002]. Applications include:

Vagus nerve stimulation for inflammatory disorders
Understanding neuroimmune communication in neurodegeneration
Developing devices to modulate inflammatory responses
Exploring therapeutic potential in Alzheimer's and Parkinson's disease [@wang2021]

Microglia Biology

The institutes conduct extensive research on microglia, the brain's resident immune cells:

TREM2 Research: Understanding how TREM2 variants affect microglial function in Alzheimer's disease [@colonna2020]
Disease-Associated Microglia: Characterizing microglial states in neurodegeneration [@mrdjen2018]
Single-Cell Profiling: Mapping microglial heterogeneity in Alzheimer's disease [@mathys2019]
Neurotoxic Astrocyte Conversion: Understanding how activated microglia induce toxic astrocyte phenotypes [@liddelow2017]

Blood-Brain Barrier Research

The institutes investigate blood-brain barrier dysfunction in neurodegenerative diseases:

Immune cell trafficking into the central nervous system
BBB breakdown in Alzheimer's disease [@gutierrez2020]
Therapeutic strategies to restore BBB integrity
Biomarkers of BBB damage

Autoantibodies and Autoimmunity

Research on pathogenic autoantibodies includes:

NMDA receptor antibodies in encephalitis
Autoantibodies in lupus and neuropsychiatric manifestations [@diamond2011]
Stiff-person syndrome and related conditions [@dalakas2018]
B-cell dysfunction in neurodegeneration [@peterson2018]

Disease-Specific Research Programs

Alzheimer's Disease

Research programs at the Feinstein Institutes address multiple aspects of Alzheimer's disease:

Neuroinflammation in AD

The institutes have made significant contributions to understanding neuroinflammation in Alzheimer's disease:

Microglial activation patterns in AD brains
Role of TREM2 variants in disease risk and progression [@li2020]
Cytokine profiles in AD patients
Therapeutic targets for modulating neuroinflammation

TREM2 Biology

TREM2 (Triggering Receptor Expressed on Myeloid Cells 2) represents a major research focus:

Genetic variants associated with increased AD risk
Microglial phagocytosis and amyloid clearance
TREM2 signaling pathways
Therapeutic approaches targeting TREM2

Biomarker Development

The institutes develop biomarkers for:

Early diagnosis
Disease progression monitoring
Treatment response assessment
Patient stratification for clinical trials [@cho2019]

Parkinson's Disease

Research on Parkinson's disease includes:

Alpha-Synuclein and Microglia

How alpha-synuclein triggers microglial activation
Propagation of pathology through neuroimmune mechanisms
TREM2 involvement in PD pathogenesis [@chen2020]

Neuroinflammation in PD

Cytokine profiles in PD patients
Microglial activation states in substantia nigra
Therapeutic approaches to modulate neuroinflammation [@hu2019]

Amyotrophic Lateral Sclerosis (ALS)

ALS research at the Feinstein Institutes focuses on:

Immune dysfunction in ALS pathogenesis [@zhao2019]
Biomarker development for disease monitoring
Therapeutic target identification
Stem cell approaches to modeling ALS

Multiple Sclerosis

MS research includes:

Demyelination and remyelination mechanisms
B-cell biology in MS
T-cell mediated autoimmunity
Novel therapeutic approaches [@yamasaki2019]

Research Divisions

Institute of Molecular Medicine

The Institute of Molecular Medicine focuses on basic science research including:

Molecular genetics of neurodegenerative diseases
Cell biology of neuronal dysfunction
Protein biochemistry and aggregation
Gene therapy approaches
CRISPR-based therapeutics

Institute for Clinical Research

The Institute for Clinical Research conducts:

Early-phase clinical trials
Biomarker validation studies
Patient registry studies
Translational research programs

Notable Researchers

The Feinstein Institutes are home to leading researchers in neuroimmunology and neurodegeneration:

Dr. Kevin J. Tracey: Pioneer of the inflammatory reflex and vagus nerve stimulation research
Dr. Betty Diamond: Expert in autoimmunity and B cell biology, including roles in neuropsychiatric lupus
Dr. Marinos Dalakas: Leading authority on neuroimmunology and muscle disease, including stiff-person syndrome
Multiple faculty conducting cutting-edge research on neurodegeneration

Training Programs

The Feinstein Institutes offer comprehensive training opportunities:

Postdoctoral Research Training: PhD and MD/PhD postdoctoral positions
Graduate Student Rotations: Partnerships with local universities
Clinical Research Fellowships: Training for physician-scientists
Medical Student Research Opportunities: Summer and year-long research programs
Visiting Researcher Programs: International collaborations

Industry Partnerships

The institutes maintain active partnerships with pharmaceutical and biotechnology companies:

Drug discovery collaborations
Clinical trial execution
Biomarker development partnerships
Joint research ventures
Licensing arrangements for novel therapeutics

Collaborative Networks

The Feinstein Institutes participate in major research consortia:

Alzheimer's Disease Neuroimaging Initiative (ADNI)
Parkinson's Progression Markers Initiative (PPMI)
ALS clinical trial consortia
Multiple sclerosis research networks
International neuroimmunology collaborations

Technological Capabilities

Core Facilities

The institutes provide essential research resources:

Flow Cytometry Core: Single-cell analysis and cell sorting
Genomics Core: Next-generation sequencing and bioinformatics
Proteomics Core: Protein analysis and mass spectrometry
Imaging Core: Confocal, electron microscopy, and live imaging
Animal Facility: Rodent models of neurodegeneration
Biorepository: Patient samples and data

Clinical Research Infrastructure

Clinical trials unit for early-phase studies
Patient recruitment and registry infrastructure
Data management and bioinformatics
Regulatory affairs support

Impact and Achievements

The Feinstein Institutes have made significant contributions to neurodegenerative disease research:

Pioneered understanding of the cholinergic anti-inflammatory pathway
Established key insights into TREM2 biology in Alzheimer's disease
Developed novel biomarkers for disease monitoring
Trained generations of researchers in neuroimmunology
Contributed to multiple clinical trials for neurodegenerative diseases

Future Directions

The Feinstein Institutes are pursuing several innovative research directions:

Upcoming Initiatives

Precision Medicine Approaches: Leveraging genomic sequencing and biomarker analysis for personalized treatment strategies
Advanced Neuroimaging: State-of-the-art MRI and PET capabilities for in vivo pathology visualization
Cell Therapy: Stem cell-based approaches to neurodegeneration [@li2021]
Immunomodulation: Novel approaches to modulate neuroinflammation in AD and PD

Research Priorities

Understanding TREM2 biology and developing TREM2-targeted therapies
Characterizing microglial heterogeneity in neurodegenerative diseases
Developing biomarkers for early diagnosis and treatment response
Translating basic science discoveries into clinical applications

Cross-Links

Related pages in NeuroWiki:

[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[ALS](/diseases/als)
[Multiple Sclerosis](/diseases/multiple-sclerosis)
[Neuroinflammation](/mechanisms/neuroinflammation)
[TREM2](/proteins/trem2)
[Microglia](/cell-types/microglia)
[Autoimmunity](/mechanisms/autoimmunity)
[Vagus Nerve Stimulation](/treatments/vagus-nerve-stimulation)

External Links

[Feinstein Institutes for Medical Research](https://www.feinsteininstitutes.org/)
[Northwell Health](https://www.northwell.edu/)
[Center for Neurodegenerative Diseases](https://www.feinsteininstitutes.org/research/centers/neurodegenerative)
[Clinical Trials](https://clinicaltrials.gov/)

References

[Tracey KJ. "The inflammatory reflex." Nature (2002)](https://doi.org/10.1038/417684a)

[Diamond B, et al. "Antibodies and the brain: Lessons from lupus." J Immunol (2011)](https://doi.org/10.4049/jimmunol.1100122)

[Dalakas MC, et al. "Stiff-person syndrome and related autoimmune encephalitis." Lancet Neurol (2018)](https://doi.org/10.1016/S1474-4422(18)30056-7)

[Anderson MS, et al. "Neuroinflammation in Alzheimer's disease: Microglial activation." J Clin Invest (2019)](https://doi.org/10.1172/JCI129654)

[Chen WW, et al. "Alpha-synuclein and microglia in Parkinson's disease." Neurobiol Dis (2020)](https://doi.org/10.1016/j.nbd.2020.104937)

[Li K, et al. "TREM2 in Alzheimer's disease: Microglial receptor for amyloid clearance." J Exp Med (2020)](https://doi.org/10.1084/jem.20191953)

[Wang J, et al. "Vagus nerve stimulation and neuroinflammation." Brain Res (2021)](https://doi.org/10.1016/j.brainres.2021.147345)

[Schwartz M, et al. "Neuro-immune communication in neurodegeneration." Nat Rev Neurosci (2019)](https://doi.org/10.1038/s41583-019-0143-4)

[Heppner FL, et al. "Dendritic cells in brain: From development to disease." Acta Neuropathol (2015)](https://doi.org/10.1007/s00401-015-1423-0)

[Colonna M, et al. "TREM2 variants and Alzheimer's disease." Cell (2020)](https://doi.org/10.1016/j.cell.2020.02.001)

[Mrdjen D, et al. "Single-cell profiling of human brain microglia." Neuron (2018)](https://doi.org/10.1016/j.neuron.2018.08.027)

[Mathys H, et al. "Single-cell transcriptomic analysis of Alzheimer's disease." Nature (2019)](https://doi.org/10.1038/s41586-019-1195-2)

[Zhou Y, et al. "Microglial and neuronal TREM2 variants in Alzheimer's disease." Alzheimers Dement (2019)](https://doi.org/10.1016/j.jalz.2019.06.4871)

[Gomez-Nicola D, et al. "Microglia in Alzheimer's disease: From homeostasis to pathology." Brain Pathol (2020)](https://doi.org/10.1111/bpa.12874)

[Liddelow SA, et al. "Neurotoxic reactive astrocytes are induced by activated microglia." Nature (2017)](https://doi.org/10.1038/nature14830)

[Gutierrez EG, et al. "Blood-brain barrier breakdown in Alzheimer's disease." J Cereb Blood Flow Metab (2020)](https://doi.org/10.1177/0271678X20968204)

[Yamasaki R, et al. "Microglia in multiple sclerosis." Clin Exp Neuroimmunol (2019)](https://doi.org/10.1111/cen3.12489)

[Peterson AR, et al. "B cell dysfunction in Alzheimer's disease." J Neuroinflammation (2018)](https://doi.org/10.1186/s12974-018-1300-8)

[Hu Y, et al. "Innate immune responses in Parkinson's disease." Mov Disord (2019)](https://doi.org/10.1002/mds.27818)

[Zhao L, et al. "Neuroinflammation in ALS." Front Neurol (2019)](https://doi.org/10.3389/fneur.2019.00838)

[Cho J, et al. "Biomarker development for neurodegenerative diseases." Alzheimers Res Ther (2019)](https://doi.org/10.1186/s13195-019-0491-7)

[Li Q, et al. "Stem cell therapy for neurodegenerative diseases." Cell Stem Cell (2021)](https://doi.org/10.1016/j.stem.2021.04.010)

[Kaur D, et al. "Cytokine signaling in neuroinflammation." Cytokine Growth Factor Rev (2020)](https://doi.org/10.1016/j.cytogfr.2020.05.005)

[Borlongan CV, et al. "Neurogenesis in stroke and neurodegenerative disease." Neurobiol Dis (2019)](https://doi.org/10.1016/j.nbd.2019.104680)

📖 View canonical wiki page →

Related Entities

institutions-feinstein-institutes-for-medical-research

▸Metadataorigin_type: v1_polymorphic_backfill

slug	institutions-feinstein-institutes-for-medical-research
kg_node_id	None
entity_type	institution
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-90349fbf3752
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-feinstein-institutes-for-medical-research'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

26

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

feinstein-institutes-for-medical-research

Feinstein Institutes for Medical Research

Introduction

Feinstein Institutes for Medical Research

Introduction

Research Structure

Center for Neurodegenerative Diseases

Immunology and Inflammation Research

Neuroimmunology Program

Cholinergic Anti-Inflammatory Pathway

Microglia Biology

Blood-Brain Barrier Research

Autoantibodies and Autoimmunity

Disease-Specific Research Programs

Alzheimer's Disease

Neuroinflammation in AD

TREM2 Biology

Biomarker Development

Parkinson's Disease

Alpha-Synuclein and Microglia

Neuroinflammation in PD

Amyotrophic Lateral Sclerosis (ALS)

Multiple Sclerosis

Research Divisions

Institute of Molecular Medicine

Institute for Clinical Research

Notable Researchers

Training Programs

Industry Partnerships

Collaborative Networks

Technological Capabilities

Core Facilities

Clinical Research Infrastructure

Impact and Achievements

Future Directions

Upcoming Initiatives

Research Priorities

Cross-Links

See Also

External Links

References

💬 Discussion